Please login to the form below

Not currently logged in
Email:
Password:

New head of Lilly oncology

Eli Lilly has appointed Sue Mahony to the role of senior vice president and president of Lilly Oncology

Sue Mahony, currently senior vice president of human resources and diversity, is to become senior vice president and president of Lilly Oncology, replacing John H Johnson, who left the company last month.

Mahony will continue to report to CEO John Lechleiter and will remain on the company's executive committee. Her new position is effective immediately.

Since his departure from Lilly, Johnson has taken over the reins at Savient Pharmaceutical, which is in the process of bringing its gout drug Krystexxa (pegloticase) to market in the US. He was previously CEO of ImClone Systems, and joined Lilly when it acquired the cancer-focused biotech company in 2008.

Steve Fry, currently vice president of human resources for bio-medicines and emerging markets, will take Mahony's old post and will join Lilly's executive leadership team. Fry was managing director of Lilly's Australian affiliate from 2004 to 2007, before becoming executive director of HR for the intercontinental region and Japan. 

Mahony, who has been with Lilly for more than 10 years, was named to the top HR position in 2009. The year before, she had been promoted to serve as general manager of Lilly, following a number of positions in the company's global marketing and new product development operations.

Before joining Lilly, she spent a decade in sales and marketing roles in the UK and Europe in oncology/hematology and cardiovascular medicine for Amgen, Bristol-Myers Squibb (BMS), and Schering-Plough. She holds a PhD in pharmacy from Aston University in the UK, and an MBA from the London Business School. 

Lilly Oncology's portfolio of marketed drugs includes the non-small cell lung cancer treatment Alimta and the ovarian cancer therapy Gemzar. The company has also declared a commitment to developing personalised cancer medications.

11th February 2011

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...
InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....

Infographics